Funding for this research was provided by:
Bill and Melinda Gates Foundation (OPP1141988)
Silicon Valley Community Foundation (0-77157)
open philanthropy project fund (2016-161185)
Received: 14 September 2020
Accepted: 31 December 2020
First Online: 21 January 2021
: All co-authors have interests that might be perceived as competing interests as they are working for Target Malaria, a not-for-profit project developing gene drive technologies to complement existing tools for malaria control.